R Bachinski, E Saggioro, C Caldeira, C Abreu… - …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > January ...
PV Mohanan, S Banerjee… - Journal of Pharmaceutical and …, 2011 - Elsevier The objective of the study is to detect the pyrogenicity of five medical grade gelatinous polymer materials, intended for the manufacturing of capsule for pharmaceutical applications, by an indigenously developed ELISA, LAL and rabbit pyrogen assays. The ELISA methodology includes the ... All 2 versions
SF Williams, DP Martin, T Gerngross… - US Patent …, 2011 - Google Patents US 7,906 135 B2 1 MEDICAL DEVICE COMPRISING POLYHYDROXYALKANOATE HAVING PYROGEN REMOVED CROSS-REFERENCE TO RELATED 5 APPLICATIONS This application is a Continuation of Ser. No. 10/642,026, filed on Aug. 15, 2003 now US Pat. No. ... Related articles - All 3 versions
M ZHENG, Y TIE, L LI… - Chinese Journal of Veterinary Drug, 2011 - en.cnki.com.cn The characteristics and features of the rabbit and the endotoxin methods were introduced briefly.With the increasingly demand for clinical,the cell pyrogen method will be gradual as the into practice as the technology development.This paper made these brief Introduction. ... Related articles - Cached
BW Neun… - Methods in molecular biology (Clifton, NJ), 2011 - Springer ... Page 3. 123 Endotoxin Contamination in Nanoparticle Samples 1. Analyte nanoparticle sample (NS; see Notes 1 and 2) reconstituted in either pyrogen-free water or sterile pyrogen-free PBS to a final concentration of 1.0 mg/mL (requires approximately 1.0 mg of nanomaterial). ... All 2 versions